Stockreport

InMed Pharmaceuticals GAAP EPS of -$8.36, revenue of $4.94M [Seeking Alpha]

InMed Pharmaceuticals Inc. - Common Shares  (INM) 
PDF Cash of $11.1M to support pharmaceutical developments into the fourth quarter of calendar year 2026. More on InMed Pharmaceuticals InMed Pharmaceuticals announces $ [Read more]